A Study on Expression of PTEN Immunohistochemical Marker in Prostatic Carcinoma

Background: Loss of the tumour suppressor PTEN activates PI3K-AKT-mTOR signalling and is linked to aggressive prostate cancer. Data from transurethral resection of the prostate (TURP) specimens are limited. Aim: To assess PTEN expression by immunohistochemistry (IHC) in prostatic carcinoma and correlate it with clinicopathological parameters. Materials and Methods: Twenty-five TURP specimens with histologically confirmed prostatic carcinoma were studied (January 2024-April 2026). Tumours were graded by the Gleason system and ISUP grade group (GG). PTEN IHC was performed on formalin-fixed paraffin-embedded sections; loss was defined as complete absence of tumour-cell staining with preserved internal controls. Associations were tested by Fisher's exact test. Results: Patients were aged 54-86 years (mean 71.7 ± 8.5). There were 11 low-grade (GG 1-3) and 11 high-grade (GG 4-5) adenocarcinomas, one case of high-grade prostatic intraepithelial neoplasia and two metastatic deposits (ungraded). PTEN loss was seen in 10 cases (40%). It occurred in 4 of 11 low-grade (36.4%) and 6 of 11 high-grade tumours (54.5%) (p = 0.67). Perineural and lymphovascular invasion were present in 28% and 8% of cases, without significant association with PTEN status. Conclusion: PTEN loss is common in TURP-detected prostatic carcinoma and shows a non-significant trend towards higher grade, with loss also seen in some low-grade tumours. PTEN IHC is an inexpensive adjunct worth testing in larger studies with outcome data.

Authors

Institutions

Publication Details

Journal
International Journal of Science and Research (IJSR)
Published
2026-11-12
DOI
https://doi.org/10.21275/sr261109204428
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Study on Expression of PTEN Immunohistochemical Marker in Prostatic Carcinoma

V Kamaldeep, G Vahini, G Mary Niharika, P Uma Rani P
International Journal of Science and Research (IJSR)
Prostate Cancer Treatment and Research
article

A Study on Expression of PTEN Immunohistochemical Marker in Prostatic Carcinoma

V Kamaldeep, G Vahini, G Mary Niharika, P Uma Rani P
article en

Abstract

Background: Loss of the tumour suppressor PTEN activates PI3K-AKT-mTOR signalling and is linked to aggressive prostate cancer. Data from transurethral resection of the prostate (TURP) specimens are limited. Aim: To assess PTEN expression by immunohistochemistry (IHC) in prostatic carcinoma and correlate it with clinicopathological parameters. Materials and Methods: Twenty-five TURP specimens with histologically confirmed prostatic carcinoma were studied (January 2024-April 2026). Tumours were graded by the Gleason system and ISUP grade group (GG). PTEN IHC was performed on formalin-fixed paraffin-embedded sections; loss was defined as complete absence of tumour-cell staining with preserved internal controls. Associations were tested by Fisher's exact test. Results: Patients were aged 54-86 years (mean 71.7 ± 8.5). There were 11 low-grade (GG 1-3) and 11 high-grade (GG 4-5) adenocarcinomas, one case of high-grade prostatic intraepithelial neoplasia and two metastatic deposits (ungraded). PTEN loss was seen in 10 cases (40%). It occurred in 4 of 11 low-grade (36.4%) and 6 of 11 high-grade tumours (54.5%) (p = 0.67). Perineural and lymphovascular invasion were present in 28% and 8% of cases, without significant association with PTEN status. Conclusion: PTEN loss is common in TURP-detected prostatic carcinoma and shows a non-significant trend towards higher grade, with loss also seen in some low-grade tumours. PTEN IHC is an inexpensive adjunct worth testing in larger studies with outcome data.

International Journal of Science and Research (IJSR)
Academy of Medical Sciences (GB)
Good health and well-being
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon